SAN FRANCISCO (MarketWatch) -- Perrigo Co. after Monday's closing bell said the Food and Drug Administration has granted tentative approval for its ciclopirox topical solution, 8%. The solution is a ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback